Related Experiment Videos
Human somatomedin A and longitudinal bone growth in the hypophysectomized rat
Molecular and Cellular Endocrinology
|January 1, 1977
Abstract:
A somatomedin A preparation, when given at total doses of 14 and 70 U did not increase the longitudinal bone growth in hypophysectomized rats. Growth hormone (WHO) significantly increased the longitudinal bone growth.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: results from a two-year controlled prospective study.
The Journal of clinical endocrinology and metabolism·2008
The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients.
The Journal of clinical endocrinology and metabolism·2006
Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
Drug metabolism and disposition: the biological fate of chemicals·2004
Growth hormone enhances proinflammatory cytokine production by monocytes in whole blood.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society·2003
RGS6 drives myocyte loss in the diabetic heart via a KLF4/miR-30e/CaMKII-dependent mechanism.
Molecular and cellular endocrinology·2026
Role of omentin-1 in the global proteome of porcine pituitary cells: insights into proliferation- and apoptosis-related processes.
Molecular and cellular endocrinology·2026
taVNS alleviates preeclampsia-induced placental trophoblast dysfunction by attenuating endoplasmic reticulum Ca2+ dysregulation via ACh-M3AChR-PERK/IP3R1 signaling.
Molecular and cellular endocrinology·2026
Regulation of the rainbow trout spleen corticotropin-releasing factor system in response to inflammatory challenges: roles of NF-κB and cortisol.
Molecular and cellular endocrinology·2026
Bergamot (Citrus bergamia) preserves cardiac structure and function and modulates myocardial redox and metabolic profiles in diet-induced obesity.
Molecular and cellular endocrinology·2026
Outcome measures used to assess gastrointestinal tract involvement in adults and children with systemic sclerosis: a scoping review.
Clinical and experimental rheumatology·2026
Type 5 diabetes mellitus: revisiting malnutrition-related diabetes.
Endokrynologia Polska·2026
Inflammatory Crosstalk Driven by Metabolic and Hemodynamic Stress in Diabetic Nephropathy.
Recent advances in inflammation & allergy drug discovery·2026
Optimizing Nutrition Strategies for Diabetes Management in India: An Expert Opinion.
Diabetes, metabolic syndrome and obesity : targets and therapy·2026